These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
322 related articles for article (PubMed ID: 7504101)
1. Permeability enhancement in Caco-2 cell monolayers by sodium salicylate and sodium taurodihydrofusidate: assessment of effect-reversibility and imaging of transepithelial transport routes by confocal laser scanning microscopy. Hurni MA; Noach AB; Blom-Roosemalen MC; de Boer AG; Nagelkerke JF; Breimer DD J Pharmacol Exp Ther; 1993 Nov; 267(2):942-50. PubMed ID: 7504101 [TBL] [Abstract][Full Text] [Related]
2. Effects of absorption enhancers on the transport of model compounds in Caco-2 cell monolayers: assessment by confocal laser scanning microscopy. Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M J Pharm Sci; 1997 Jul; 86(7):779-85. PubMed ID: 9232516 [TBL] [Abstract][Full Text] [Related]
3. Confocal laser scanning microscopic visualization of the transport of dextrans after nasal administration to rats: effects of absorption enhancers. Marttin E; Verhoef JC; Cullander C; Romeijn SG; Nagelkerke JF; Merkus FW Pharm Res; 1997 May; 14(5):631-7. PubMed ID: 9165535 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers. Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048 [TBL] [Abstract][Full Text] [Related]
5. Absorption enhancement of hydrophilic compounds by verapamil in Caco-2 cell monolayers. Sakai M; Noach AB; Blom-Roosemalen MC; de Boer AG; Breimer DD Biochem Pharmacol; 1994 Sep; 48(6):1199-210. PubMed ID: 7524505 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of bile acids and fusidate derivative as nasal absorption enhancers using an electrophysiological technique. Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y Biol Pharm Bull; 1999 Oct; 22(10):1089-93. PubMed ID: 10549861 [TBL] [Abstract][Full Text] [Related]
7. Effect of sodium taurodihydrofusidate on nasal drug delivery: differences in its concentration and penetrant molecular weight. Hosoya K; Kubo H; Akutsu T; Natsume H; Sugibayashi K; Morimoto Y Arch Pharm Res; 1994 Apr; 17(2):57-9. PubMed ID: 10319131 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of enhancers to increase nasal absorption using Ussing chamber technique. Hosoya K; Kubo H; Natsume H; Sugibayashi K; Morimoto Y Biol Pharm Bull; 1994 Feb; 17(2):316-22. PubMed ID: 7515747 [TBL] [Abstract][Full Text] [Related]
9. Effect of anisotonic conditions on the transport of hydrophilic model compounds across monolayers of human colonic cell lines. Noach AB; Sakai M; Blom-Roosemalen MC; de Jonge HR; de Boer AG; Breimer DD J Pharmacol Exp Ther; 1994 Sep; 270(3):1373-80. PubMed ID: 7523659 [TBL] [Abstract][Full Text] [Related]
10. Rectal absorption enhancement of cefoxitin and desglycinamide arginine vasopressin by sodium tauro-24,25-dihydrofusidate in conscious rats. van Hoogdalem EJ; Heijligers-Feijen CD; Mathôt RA; Wackwitz AT; van Bree JB; Verhoef JC; de Boer AG; Breimer DD J Pharmacol Exp Ther; 1989 Nov; 251(2):741-4. PubMed ID: 2810123 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Caco-2 monolayer as a model epithelium for iontophoretic transport. Leonard M; Creed E; Brayden D; Baird AW Pharm Res; 2000 Oct; 17(10):1181-8. PubMed ID: 11145222 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous use of sodium deoxycholate and dipotassium glycyrrhizinate enhances the cellular transport of poorly absorbed compounds across Caco-2 cell monolayers. Sakai M; Imai T; Ohtake H; Azuma H; Otagiri M J Pharm Pharmacol; 1999 Jan; 51(1):27-33. PubMed ID: 10197414 [TBL] [Abstract][Full Text] [Related]
13. Absorption enhancement of rectally infused insulin by sodium tauro-24,25-dihydrofusidate (STDHF) in rats. van Hoogdalem EJ; Heijligers-Feijen CD; Verhoef JC; de Boer AG; Breimer DD Pharm Res; 1990 Feb; 7(2):180-3. PubMed ID: 2106676 [TBL] [Abstract][Full Text] [Related]
14. Absorption enhancement in intestinal epithelial Caco-2 monolayers by sodium caprate: assessment of molecular weight dependence and demonstration of transport routes. Lindmark T; Schipper N; Lazorová L; de Boer AG; Artursson P J Drug Target; 1998; 5(3):215-23. PubMed ID: 9606011 [TBL] [Abstract][Full Text] [Related]
15. Novel oral absorption system containing polyamines and bile salts enhances drug transport via both transcellular and paracellular pathways across Caco-2 cell monolayers. Mukaizawa F; Taniguchi K; Miyake M; Ogawara K; Odomi M; Higaki K; Kimura T Int J Pharm; 2009 Feb; 367(1-2):103-8. PubMed ID: 18929635 [TBL] [Abstract][Full Text] [Related]
17. Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects. Kissel T; Drewe J; Bantle S; Rummelt A; Beglinger C Pharm Res; 1992 Jan; 9(1):52-7. PubMed ID: 1589410 [TBL] [Abstract][Full Text] [Related]
18. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules. Thanou M; Henderson S; Kydonieus A; Elson C J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870 [TBL] [Abstract][Full Text] [Related]
19. Effects of absorption enhancers on human nasal tissue ciliary movement in vitro. Hermens WA; Hooymans PM; Verhoef JC; Merkus FW Pharm Res; 1990 Feb; 7(2):144-6. PubMed ID: 2408030 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). Kotzé AF; Luessen HL; de Leeuw BJ; de Boer AG; Verhoef JC; Junginger HE J Control Release; 1998 Jan; 51(1):35-46. PubMed ID: 9685902 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]